Qian, Chongsheng <br/><br/>
Curative or pre-emptive adenovirus-specific T cell transfer from matched unrelated or third party haploidentical donors after HSCT, including UCB transplantations: a successful phase I/II multicenter clinical trial.  [electronic resource] 

 -  Journal of hematology & oncology  05 2017 
 - 102 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>1756-8722 
<br/><br/><label>Standard No.: </label>10.1186/s13045-017-0469-0  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenovirus Infections, Human--blood<br/>Adenoviruses, Human--immunology<br/>Adolescent<br/>Adult<br/>Allografts<br/>Child<br/>Cord Blood Stem Cell Transplantation<br/>Female<br/>Graft vs Host Disease--drug therapy<br/>Humans<br/>Immunomagnetic Separation<br/>Immunosuppressive Agents--adverse effects<br/>Immunotherapy, Adoptive--methods<br/>Interferon-gamma--metabolism<br/>Leukapheresis<br/>Male<br/>T-Cell Antigen Receptor Specificity<br/>T-Lymphocyte Subsets--immunology<br/>Tissue Donors<br/>Transplantation, Haploidentical<br/>Treatment Outcome<br/>Viral Load<br/>Viremia--therapy<br/>Virus Activation<br/>Young Adult